Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma

被引：0
|
作者：
Falcone, Umberto [1 ,2 ]
Jiang, Haiyan [3 ]
Bashir, Shaheena [3 ]
Tsang, Richard [4 ]
Kukreti, Vishal [1 ,2 ]
Keating, Armand [1 ,2 ]
Crump, Michael [1 ,2 ]
Kuruvilla, John [1 ,2 ]
机构：
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷 / 03期
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PLUS RITUXIMAB; FREE SURVIVAL; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; SUPERIOR; THERAPY; CHOP;
D O I：
10.1038/s41409-017-0054-8
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：347 / 351
页数：5
相关论文
共 50 条
  • [21] Population-based study of patients with mantle cell lymphoma; era by era improvement in survival mediated by first-line rituximab and autologous stem cell transplantation
    Joshi, K.
    Hubbard, R.
    Bishton, M. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 94 - 94
  • [22] First-line autologous transplantation in stem cell primary CNS lymphoma
    Brevet, M
    Garidi, R
    Gruson, B
    Royer, B
    Vaida, I
    Damaj, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (04) : 288 - 292
  • [23] Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation
    Moniba Nazeef
    Brad S. Kahl
    Current Treatment Options in Oncology, 2015, 16
  • [24] Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation
    Nazeef, Moniba
    Kahl, Brad S.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (06)
  • [25] Maintenance Rituximab after High-Dose Therapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
    Roider, Tobias
    Dietrich, Sascha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1811 - 1812
  • [26] Rituximab Maintenance Therapy after Autologous Stem Cell Transplantation Improves Survival of Patients with Mantle Cell Lymphoma
    Graf, Solomon A.
    Stevenson, Philip A.
    Holmberg, Leona A.
    Till, Brian G.
    Press, Oliver W.
    Chauncey, Thomas R.
    Smith, Stephen D.
    Philip, Mary
    Orozco, Johnnie J.
    Shustov, Andrei R.
    Green, Damian J.
    Libby, Edward N.
    Bensinger, William I.
    Pagel, John M.
    Maloney, David G.
    Zhou, Yi
    Cassaday, Ryan D.
    Gopal, Ajay K.
    BLOOD, 2014, 124 (21)
  • [27] Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial
    Romancik, Jason T.
    Chen, Zhengjia
    Allen, Pamela B.
    Waller, Edmund K.
    Valla, Kelly
    Colbert, Amanda
    Rosand, Cecilia
    Palmer, Alexandra F.
    Flowers, Christopher R.
    Cohen, Jonathon B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (12): : E1084 - E1091
  • [28] Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab
    Mei, Matthew G.
    Cao, Thai M.
    Chen, Lu
    Song, Joo Y.
    Siddiqi, Tanya
    Cai, Ji-Lian
    Farol, Leonardo T.
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Aldoss, Ibrahim
    Palmer, Joycelynne
    Herrera, Alex F.
    Zain, Jasmine
    Popplewell, Leslie L.
    Chen, Robert W.
    Rosen, Steven T.
    Forman, Stephen J.
    Kwak, Larry
    Nademanee, Auayporn P.
    Budde, Lihua E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1861 - 1869
  • [29] R-GIFOX (RITUXIMAB, GEMCITABINE, IFOSFAMIDE, OXALIPLATIN) PLUS RITUXIMAB MAINTENANCE AS FIRST-LINE STRATEGY IN CLASSICAL MANTLE CELL LYMPHOMA
    Corazzelli, G.
    Capobianco, G.
    Arcamone, M.
    Frigeri, F.
    Russo, F.
    Marcacci, G.
    Di Francia, R.
    Becchimanzi, C.
    Morelli, E.
    Volzone, F.
    Pinto, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 221 - 221
  • [30] Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
    Le Gouill, S.
    Thieblemont, C.
    Oberic, L.
    Moreau, A.
    Bouabdallah, K.
    Dartigeas, C.
    Damaj, G.
    Gastinne, T.
    Ribrag, V.
    Feugier, P.
    Casasnovas, O.
    Zerazhi, H.
    Haioun, C.
    Maisonneuve, H.
    Houot, R.
    Jardin, F.
    Van den Neste, E.
    Tournilhac, O.
    Le Du, K.
    Morschhauser, F.
    Cartron, G.
    Fornecker, L. -M.
    Canioni, D.
    Callanan, M.
    Bene, M. C.
    Salles, G.
    Tilly, H.
    Lamy, T.
    Gressin, R.
    Hermine, O.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13): : 1250 - 1260
12345